B. Riley Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.9K Sell
200
-19,800
-99% -$4.26M ﹤0.01% 869
2026
Q1
$42.6K Buy
20,000
+19,800
+9,900% +$4.39M ﹤0.01% 834
2025
Q4
$45.7K Sell
200
-19,800
-99% -$4.51M ﹤0.01% 978
2025
Q3
$46.3K Buy
20,000
+19,800
+9,900% +$4.03M ﹤0.01% 1004
2025
Q2
$37.1K Buy
+200
New +$37.2K ﹤0.01% 999

Other funds holding ABBV

B. Riley Wealth Advisors's ABBV Position: Q2 2026 in Review

B. Riley Wealth Advisors increased its AbbVie (ABBV) stake by 4.2% in Q2 2026, buying an estimated $281K and bringing the position to 32,220 shares worth $8.19M. The position accounts for 0.44% of the portfolio, ranked #49.

B. Riley Wealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.8M in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • B. Riley Wealth Advisors held 32,220 shares of AbbVie worth $8.19M as of Q2 2026.
  • B. Riley Wealth Advisors bought 1,308 AbbVie shares in Q2 2026, an estimated $281K.
  • AbbVie made up 0.44% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #49 holding.
  • B. Riley Wealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • B. Riley Wealth Advisors's AbbVie position peaked at $30.8M in Q4 2022.
  • 1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.